INHBA and cancer: The ratio of INHBA(+) CAFs in patients was higher in metastatic HGSOC tumors (synchronous and metachronous) compared to patient-matched primary tumors, implying either a phenotypic switch in fibroblasts imparted by the cancer cells during disease progression or recruitment of a distinct population of CAFs at the metastatic site compared to primary site.